nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Etoposide—brain cancer	0.731	1	CiPCiCtD
Irinotecan—UGT1A1—Etoposide—brain cancer	0.0255	0.165	CbGbCtD
Irinotecan—ABCC1—Etoposide—brain cancer	0.0209	0.136	CbGbCtD
Irinotecan—ABCC2—Carboplatin—brain cancer	0.0184	0.12	CbGbCtD
Irinotecan—ABCG2—Carboplatin—brain cancer	0.0167	0.108	CbGbCtD
Irinotecan—ABCC2—Etoposide—brain cancer	0.0155	0.101	CbGbCtD
Irinotecan—CYP3A4—Temozolomide—brain cancer	0.0147	0.0956	CbGbCtD
Irinotecan—ABCG2—Etoposide—brain cancer	0.014	0.0909	CbGbCtD
Irinotecan—CYP3A4—Lomustine—brain cancer	0.0125	0.0812	CbGbCtD
Irinotecan—CYP3A5—Etoposide—brain cancer	0.00776	0.0504	CbGbCtD
Irinotecan—ABCB1—Etoposide—brain cancer	0.00505	0.0328	CbGbCtD
Irinotecan—CYP3A4—Etoposide—brain cancer	0.00302	0.0196	CbGbCtD
Irinotecan—TOP1MT—gonad—brain cancer	0.000695	0.0425	CbGeAlD
Irinotecan—TOP1MT—endocrine gland—brain cancer	0.000525	0.0321	CbGeAlD
Irinotecan—TOP1MT—head—brain cancer	0.000519	0.0317	CbGeAlD
Irinotecan—TOP1MT—central nervous system—brain cancer	0.000473	0.0289	CbGeAlD
Irinotecan—TOP1MT—cerebellum—brain cancer	0.000463	0.0283	CbGeAlD
Irinotecan—TOP1—telencephalon—brain cancer	0.000439	0.0268	CbGeAlD
Irinotecan—CES2—telencephalon—brain cancer	0.000399	0.0243	CbGeAlD
Irinotecan—TOP1MT—brain—brain cancer	0.000376	0.023	CbGeAlD
Irinotecan—TOP1—pituitary gland—brain cancer	0.000358	0.0218	CbGeAlD
Irinotecan—TOP1—medulla oblongata—brain cancer	0.000345	0.0211	CbGeAlD
Irinotecan—CES2—gonad—brain cancer	0.000333	0.0203	CbGeAlD
Irinotecan—ACHE—telencephalon—brain cancer	0.000328	0.02	CbGeAlD
Irinotecan—CES2—pituitary gland—brain cancer	0.000324	0.0198	CbGeAlD
Irinotecan—TOP1—midbrain—brain cancer	0.000316	0.0193	CbGeAlD
Irinotecan—CES2—medulla oblongata—brain cancer	0.000313	0.0191	CbGeAlD
Irinotecan—UGT1A9—endocrine gland—brain cancer	0.000312	0.019	CbGeAlD
Irinotecan—TOP1—spinal cord—brain cancer	0.000308	0.0188	CbGeAlD
Irinotecan—CES2—midbrain—brain cancer	0.000286	0.0175	CbGeAlD
Irinotecan—CES2—spinal cord—brain cancer	0.000279	0.0171	CbGeAlD
Irinotecan—CYP3A7—endocrine gland—brain cancer	0.000259	0.0158	CbGeAlD
Irinotecan—ACHE—medulla oblongata—brain cancer	0.000258	0.0157	CbGeAlD
Irinotecan—CES2—endocrine gland—brain cancer	0.000251	0.0154	CbGeAlD
Irinotecan—CES2—head—brain cancer	0.000248	0.0152	CbGeAlD
Irinotecan—TOP1—cerebellum—brain cancer	0.000244	0.0149	CbGeAlD
Irinotecan—ACHE—midbrain—brain cancer	0.000236	0.0144	CbGeAlD
Irinotecan—ACHE—spinal cord—brain cancer	0.00023	0.014	CbGeAlD
Irinotecan—CES2—central nervous system—brain cancer	0.000227	0.0138	CbGeAlD
Irinotecan—CES2—cerebellum—brain cancer	0.000221	0.0135	CbGeAlD
Irinotecan—Haemoglobin—Procarbazine—brain cancer	0.000216	0.00305	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000216	0.00304	CcSEcCtD
Irinotecan—Haemorrhage—Procarbazine—brain cancer	0.000215	0.00303	CcSEcCtD
Irinotecan—UGT1A1—endocrine gland—brain cancer	0.000214	0.0131	CbGeAlD
Irinotecan—Injury—Carmustine—brain cancer	0.000211	0.00298	CcSEcCtD
Irinotecan—Decreased appetite—Lomustine—brain cancer	0.000209	0.00295	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Etoposide—brain cancer	0.000207	0.00292	CcSEcCtD
Irinotecan—CES1—endocrine gland—brain cancer	0.000207	0.0126	CbGeAlD
Irinotecan—CES1—head—brain cancer	0.000204	0.0125	CbGeAlD
Irinotecan—Pancreatitis—Hydroxyurea—brain cancer	0.000204	0.00287	CcSEcCtD
Irinotecan—Flushing—Procarbazine—brain cancer	0.000199	0.00281	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Temozolomide—brain cancer	0.000199	0.00281	CcSEcCtD
Irinotecan—TOP1—brain—brain cancer	0.000198	0.0121	CbGeAlD
Irinotecan—Hyponatraemia—Carmustine—brain cancer	0.000195	0.00275	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000194	0.00274	CcSEcCtD
Irinotecan—Neutropenia—Hydroxyurea—brain cancer	0.000194	0.00274	CcSEcCtD
Irinotecan—Chills—Procarbazine—brain cancer	0.000193	0.00272	CcSEcCtD
Irinotecan—Arrhythmia—Procarbazine—brain cancer	0.000192	0.00271	CcSEcCtD
Irinotecan—SLC22A3—gonad—brain cancer	0.00019	0.0116	CbGeAlD
Irinotecan—Body temperature increased—Lomustine—brain cancer	0.00019	0.00268	CcSEcCtD
Irinotecan—Alopecia—Procarbazine—brain cancer	0.00019	0.00268	CcSEcCtD
Irinotecan—ABCC1—telencephalon—brain cancer	0.000188	0.0115	CbGeAlD
Irinotecan—CES1—central nervous system—brain cancer	0.000187	0.0114	CbGeAlD
Irinotecan—ACHE—cerebellum—brain cancer	0.000182	0.0111	CbGeAlD
Irinotecan—BCHE—brainstem—brain cancer	0.000182	0.0111	CbGeAlD
Irinotecan—Stomatitis—Hydroxyurea—brain cancer	0.000181	0.00255	CcSEcCtD
Irinotecan—CES2—brain—brain cancer	0.00018	0.011	CbGeAlD
Irinotecan—Sepsis—Etoposide—brain cancer	0.00018	0.00253	CcSEcCtD
Irinotecan—SLCO1B1—endocrine gland—brain cancer	0.000178	0.0109	CbGeAlD
Irinotecan—Hypokalaemia—Carmustine—brain cancer	0.000177	0.00249	CcSEcCtD
Irinotecan—Dehydration—Temozolomide—brain cancer	0.000175	0.00246	CcSEcCtD
Irinotecan—Anaemia—Procarbazine—brain cancer	0.000173	0.00244	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000173	0.00244	CcSEcCtD
Irinotecan—Hypokalaemia—Temozolomide—brain cancer	0.000171	0.00241	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000169	0.00238	CcSEcCtD
Irinotecan—Syncope—Procarbazine—brain cancer	0.000168	0.00237	CcSEcCtD
Irinotecan—Leukopenia—Procarbazine—brain cancer	0.000167	0.00236	CcSEcCtD
Irinotecan—Haemoglobin—Hydroxyurea—brain cancer	0.000167	0.00236	CcSEcCtD
Irinotecan—Haemorrhage—Hydroxyurea—brain cancer	0.000166	0.00235	CcSEcCtD
Irinotecan—Loss of consciousness—Procarbazine—brain cancer	0.000164	0.00232	CcSEcCtD
Irinotecan—Abdominal distension—Temozolomide—brain cancer	0.000163	0.0023	CcSEcCtD
Irinotecan—Cough—Procarbazine—brain cancer	0.000163	0.0023	CcSEcCtD
Irinotecan—Hypertension—Procarbazine—brain cancer	0.000161	0.00228	CcSEcCtD
Irinotecan—BCHE—telencephalon—brain cancer	0.000161	0.00985	CbGeAlD
Irinotecan—ABCB1—blood vessel—brain cancer	0.000158	0.00968	CbGeAlD
Irinotecan—Sweating increased—Temozolomide—brain cancer	0.000158	0.00223	CcSEcCtD
Irinotecan—Neutropenia—Carmustine—brain cancer	0.000157	0.00221	CcSEcCtD
Irinotecan—ABCG2—telencephalon—brain cancer	0.000156	0.00952	CbGeAlD
Irinotecan—Anaphylactoid reaction—Etoposide—brain cancer	0.000155	0.00219	CcSEcCtD
Irinotecan—Confusional state—Procarbazine—brain cancer	0.000154	0.00217	CcSEcCtD
Irinotecan—ABCC1—pituitary gland—brain cancer	0.000153	0.00936	CbGeAlD
Irinotecan—Vomiting—Lomustine—brain cancer	0.000153	0.00216	CcSEcCtD
Irinotecan—Oedema—Procarbazine—brain cancer	0.000153	0.00215	CcSEcCtD
Irinotecan—Neutropenia—Temozolomide—brain cancer	0.000152	0.00214	CcSEcCtD
Irinotecan—Infection—Procarbazine—brain cancer	0.000152	0.00214	CcSEcCtD
Irinotecan—Angiopathy—Hydroxyurea—brain cancer	0.000151	0.00213	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Temozolomide—brain cancer	0.000151	0.00213	CcSEcCtD
Irinotecan—Pneumonia—Carmustine—brain cancer	0.000151	0.00212	CcSEcCtD
Irinotecan—Shock—Procarbazine—brain cancer	0.00015	0.00212	CcSEcCtD
Irinotecan—Thrombocytopenia—Procarbazine—brain cancer	0.000149	0.00211	CcSEcCtD
Irinotecan—Chills—Hydroxyurea—brain cancer	0.000149	0.0021	CcSEcCtD
Irinotecan—ACHE—brain—brain cancer	0.000148	0.00904	CbGeAlD
Irinotecan—CES1—brain—brain cancer	0.000148	0.00904	CbGeAlD
Irinotecan—Hyperhidrosis—Procarbazine—brain cancer	0.000148	0.00208	CcSEcCtD
Irinotecan—Renal failure—Carmustine—brain cancer	0.000147	0.00208	CcSEcCtD
Irinotecan—Alopecia—Hydroxyurea—brain cancer	0.000147	0.00207	CcSEcCtD
Irinotecan—Weight decreased—Temozolomide—brain cancer	0.000147	0.00207	CcSEcCtD
Irinotecan—Stomatitis—Carmustine—brain cancer	0.000146	0.00206	CcSEcCtD
Irinotecan—Pneumonia—Temozolomide—brain cancer	0.000146	0.00205	CcSEcCtD
Irinotecan—Anorexia—Procarbazine—brain cancer	0.000146	0.00205	CcSEcCtD
Irinotecan—SLC22A3—endocrine gland—brain cancer	0.000144	0.00877	CbGeAlD
Irinotecan—Cardiac arrest—Etoposide—brain cancer	0.000143	0.00202	CcSEcCtD
Irinotecan—Nausea—Lomustine—brain cancer	0.000143	0.00201	CcSEcCtD
Irinotecan—Hypotension—Procarbazine—brain cancer	0.000143	0.00201	CcSEcCtD
Irinotecan—SLC22A3—head—brain cancer	0.000142	0.00866	CbGeAlD
Irinotecan—Stomatitis—Temozolomide—brain cancer	0.000141	0.00199	CcSEcCtD
Irinotecan—Insomnia—Procarbazine—brain cancer	0.000138	0.00195	CcSEcCtD
Irinotecan—Paraesthesia—Procarbazine—brain cancer	0.000137	0.00193	CcSEcCtD
Irinotecan—Somnolence—Procarbazine—brain cancer	0.000136	0.00191	CcSEcCtD
Irinotecan—Cramp muscle—Etoposide—brain cancer	0.000135	0.00191	CcSEcCtD
Irinotecan—Haemoglobin—Carmustine—brain cancer	0.000135	0.00191	CcSEcCtD
Irinotecan—ABCC2—endocrine gland—brain cancer	0.000135	0.00823	CbGeAlD
Irinotecan—Haemorrhage—Carmustine—brain cancer	0.000134	0.0019	CcSEcCtD
Irinotecan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000134	0.00189	CcSEcCtD
Irinotecan—Anaemia—Hydroxyurea—brain cancer	0.000134	0.00189	CcSEcCtD
Irinotecan—Decreased appetite—Procarbazine—brain cancer	0.000133	0.00187	CcSEcCtD
Irinotecan—Connective tissue disorder—Carmustine—brain cancer	0.000132	0.00186	CcSEcCtD
Irinotecan—Fatigue—Procarbazine—brain cancer	0.000132	0.00186	CcSEcCtD
Irinotecan—BCHE—pituitary gland—brain cancer	0.000131	0.00802	CbGeAlD
Irinotecan—Haemoglobin—Temozolomide—brain cancer	0.000131	0.00184	CcSEcCtD
Irinotecan—Malaise—Hydroxyurea—brain cancer	0.000131	0.00184	CcSEcCtD
Irinotecan—Pain—Procarbazine—brain cancer	0.000131	0.00184	CcSEcCtD
Irinotecan—Constipation—Procarbazine—brain cancer	0.000131	0.00184	CcSEcCtD
Irinotecan—Haemorrhage—Temozolomide—brain cancer	0.00013	0.00183	CcSEcCtD
Irinotecan—Leukopenia—Hydroxyurea—brain cancer	0.00013	0.00183	CcSEcCtD
Irinotecan—Visual impairment—Carmustine—brain cancer	0.00013	0.00183	CcSEcCtD
Irinotecan—SLC22A3—central nervous system—brain cancer	0.000129	0.00791	CbGeAlD
Irinotecan—Connective tissue disorder—Temozolomide—brain cancer	0.000128	0.0018	CcSEcCtD
Irinotecan—ABCG2—pituitary gland—brain cancer	0.000127	0.00775	CbGeAlD
Irinotecan—BCHE—medulla oblongata—brain cancer	0.000127	0.00774	CbGeAlD
Irinotecan—Sweating increased—Etoposide—brain cancer	0.000127	0.00178	CcSEcCtD
Irinotecan—Feeling abnormal—Procarbazine—brain cancer	0.000126	0.00177	CcSEcCtD
Irinotecan—Visual impairment—Temozolomide—brain cancer	0.000125	0.00177	CcSEcCtD
Irinotecan—Gastrointestinal pain—Procarbazine—brain cancer	0.000125	0.00176	CcSEcCtD
Irinotecan—Flushing—Carmustine—brain cancer	0.000125	0.00176	CcSEcCtD
Irinotecan—ABCG2—medulla oblongata—brain cancer	0.000122	0.00748	CbGeAlD
Irinotecan—Discomfort—Hydroxyurea—brain cancer	0.000122	0.00172	CcSEcCtD
Irinotecan—Neutropenia—Etoposide—brain cancer	0.000121	0.00171	CcSEcCtD
Irinotecan—Body temperature increased—Procarbazine—brain cancer	0.000121	0.0017	CcSEcCtD
Irinotecan—Abdominal pain—Procarbazine—brain cancer	0.000121	0.0017	CcSEcCtD
Irinotecan—Flushing—Temozolomide—brain cancer	0.000121	0.0017	CcSEcCtD
Irinotecan—Cardiac disorder—Temozolomide—brain cancer	0.000121	0.0017	CcSEcCtD
Irinotecan—Arrhythmia—Carmustine—brain cancer	0.00012	0.00169	CcSEcCtD
Irinotecan—CYP2B6—gonad—brain cancer	0.00012	0.00733	CbGeAlD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000119	0.00437	CbGpPWpGaD
Irinotecan—Alopecia—Carmustine—brain cancer	0.000119	0.00168	CcSEcCtD
Irinotecan—Oedema—Hydroxyurea—brain cancer	0.000118	0.00167	CcSEcCtD
Irinotecan—Angiopathy—Temozolomide—brain cancer	0.000118	0.00166	CcSEcCtD
Irinotecan—Infection—Hydroxyurea—brain cancer	0.000117	0.00166	CcSEcCtD
Irinotecan—Immune system disorder—Temozolomide—brain cancer	0.000117	0.00165	CcSEcCtD
Irinotecan—Mediastinal disorder—Temozolomide—brain cancer	0.000117	0.00165	CcSEcCtD
Irinotecan—Chills—Temozolomide—brain cancer	0.000117	0.00164	CcSEcCtD
Irinotecan—Pneumonia—Etoposide—brain cancer	0.000116	0.00164	CcSEcCtD
Irinotecan—Nervous system disorder—Hydroxyurea—brain cancer	0.000116	0.00163	CcSEcCtD
Irinotecan—BCHE—midbrain—brain cancer	0.000116	0.00707	CbGeAlD
Irinotecan—Thrombocytopenia—Hydroxyurea—brain cancer	0.000116	0.00163	CcSEcCtD
Irinotecan—Alopecia—Temozolomide—brain cancer	0.000115	0.00162	CcSEcCtD
Irinotecan—Acute coronary syndrome—Etoposide—brain cancer	0.000114	0.00161	CcSEcCtD
Irinotecan—Renal failure—Etoposide—brain cancer	0.000114	0.00161	CcSEcCtD
Irinotecan—Myocardial infarction—Etoposide—brain cancer	0.000114	0.0016	CcSEcCtD
Irinotecan—Back pain—Carmustine—brain cancer	0.000113	0.0016	CcSEcCtD
Irinotecan—BCHE—spinal cord—brain cancer	0.000113	0.0069	CbGeAlD
Irinotecan—Jaundice—Etoposide—brain cancer	0.000113	0.00159	CcSEcCtD
Irinotecan—Stomatitis—Etoposide—brain cancer	0.000113	0.00159	CcSEcCtD
Irinotecan—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000113	0.00412	CbGpPWpGaD
Irinotecan—Anorexia—Hydroxyurea—brain cancer	0.000113	0.00159	CcSEcCtD
Irinotecan—Hypersensitivity—Procarbazine—brain cancer	0.000112	0.00159	CcSEcCtD
Irinotecan—ABCG2—midbrain—brain cancer	0.000112	0.00684	CbGeAlD
Irinotecan—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00011	0.00403	CbGpPWpGaD
Irinotecan—Asthenia—Procarbazine—brain cancer	0.00011	0.00154	CcSEcCtD
Irinotecan—Back pain—Temozolomide—brain cancer	0.000109	0.00154	CcSEcCtD
Irinotecan—ABCG2—spinal cord—brain cancer	0.000109	0.00667	CbGeAlD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000109	0.00398	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000109	0.00397	CbGpPWpGaD
Irinotecan—Anaemia—Carmustine—brain cancer	0.000108	0.00153	CcSEcCtD
Irinotecan—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000108	0.00394	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000106	0.00389	CbGpPWpGaD
Irinotecan—Dyspnoea—Hydroxyurea—brain cancer	0.000105	0.00149	CcSEcCtD
Irinotecan—Somnolence—Hydroxyurea—brain cancer	0.000105	0.00148	CcSEcCtD
Irinotecan—Ill-defined disorder—Temozolomide—brain cancer	0.000105	0.00148	CcSEcCtD
Irinotecan—Leukopenia—Carmustine—brain cancer	0.000105	0.00148	CcSEcCtD
Irinotecan—ABCC1—cerebellum—brain cancer	0.000105	0.00639	CbGeAlD
Irinotecan—Anaemia—Temozolomide—brain cancer	0.000105	0.00147	CcSEcCtD
Irinotecan—Diarrhoea—Procarbazine—brain cancer	0.000104	0.00147	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—CDK4—brain cancer	0.000104	0.00381	CbGpPWpGaD
Irinotecan—Dyspepsia—Hydroxyurea—brain cancer	0.000104	0.00147	CcSEcCtD
Irinotecan—ALB—brain—brain cancer	0.000103	0.00629	CbGeAlD
Irinotecan—SLC22A3—brain—brain cancer	0.000103	0.00628	CbGeAlD
Irinotecan—Decreased appetite—Hydroxyurea—brain cancer	0.000103	0.00145	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000102	0.00374	CbGpPWpGaD
Irinotecan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000102	0.00373	CbGpPWpGaD
Irinotecan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000102	0.00144	CcSEcCtD
Irinotecan—Malaise—Temozolomide—brain cancer	0.000102	0.00144	CcSEcCtD
Irinotecan—Fatigue—Hydroxyurea—brain cancer	0.000102	0.00144	CcSEcCtD
Irinotecan—BCHE—endocrine gland—brain cancer	0.000102	0.00621	CbGeAlD
Irinotecan—Vertigo—Temozolomide—brain cancer	0.000102	0.00143	CcSEcCtD
Irinotecan—Leukopenia—Temozolomide—brain cancer	0.000101	0.00143	CcSEcCtD
Irinotecan—Hypertension—Carmustine—brain cancer	0.000101	0.00142	CcSEcCtD
Irinotecan—Constipation—Hydroxyurea—brain cancer	0.000101	0.00142	CcSEcCtD
Irinotecan—Pain—Hydroxyurea—brain cancer	0.000101	0.00142	CcSEcCtD
Irinotecan—Dizziness—Procarbazine—brain cancer	0.000101	0.00142	CcSEcCtD
Irinotecan—BCHE—head—brain cancer	0.0001	0.00613	CbGeAlD
Irinotecan—CES2—E2F transcription factor network—MYC—brain cancer	9.9e-05	0.00362	CbGpPWpGaD
Irinotecan—Cough—Temozolomide—brain cancer	9.87e-05	0.00139	CcSEcCtD
Irinotecan—Hypertension—Temozolomide—brain cancer	9.76e-05	0.00138	CcSEcCtD
Irinotecan—Feeling abnormal—Hydroxyurea—brain cancer	9.74e-05	0.00137	CcSEcCtD
Irinotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	9.73e-05	0.00356	CbGpPWpGaD
Irinotecan—Vomiting—Procarbazine—brain cancer	9.71e-05	0.00137	CcSEcCtD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.7e-05	0.00355	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.7e-05	0.00355	CbGpPWpGaD
Irinotecan—Flushing—Etoposide—brain cancer	9.65e-05	0.00136	CcSEcCtD
Irinotecan—Cardiac disorder—Etoposide—brain cancer	9.65e-05	0.00136	CcSEcCtD
Irinotecan—Confusional state—Carmustine—brain cancer	9.63e-05	0.00136	CcSEcCtD
Irinotecan—Rash—Procarbazine—brain cancer	9.63e-05	0.00136	CcSEcCtD
Irinotecan—Dermatitis—Procarbazine—brain cancer	9.62e-05	0.00136	CcSEcCtD
Irinotecan—Headache—Procarbazine—brain cancer	9.56e-05	0.00135	CcSEcCtD
Irinotecan—Oedema—Carmustine—brain cancer	9.55e-05	0.00135	CcSEcCtD
Irinotecan—Discomfort—Temozolomide—brain cancer	9.51e-05	0.00134	CcSEcCtD
Irinotecan—Infection—Carmustine—brain cancer	9.49e-05	0.00134	CcSEcCtD
Irinotecan—Angiopathy—Etoposide—brain cancer	9.43e-05	0.00133	CcSEcCtD
Irinotecan—UGT1A1—Biological oxidations—CYP2C9—brain cancer	9.41e-05	0.00344	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—CYP2C9—brain cancer	9.41e-05	0.00344	CbGpPWpGaD
Irinotecan—Immune system disorder—Etoposide—brain cancer	9.39e-05	0.00132	CcSEcCtD
Irinotecan—Mediastinal disorder—Etoposide—brain cancer	9.37e-05	0.00132	CcSEcCtD
Irinotecan—Thrombocytopenia—Carmustine—brain cancer	9.35e-05	0.00132	CcSEcCtD
Irinotecan—Body temperature increased—Hydroxyurea—brain cancer	9.34e-05	0.00132	CcSEcCtD
Irinotecan—Chills—Etoposide—brain cancer	9.33e-05	0.00132	CcSEcCtD
Irinotecan—Confusional state—Temozolomide—brain cancer	9.31e-05	0.00131	CcSEcCtD
Irinotecan—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	9.28e-05	0.00339	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	9.28e-05	0.00339	CbGpPWpGaD
Irinotecan—Oedema—Temozolomide—brain cancer	9.23e-05	0.0013	CcSEcCtD
Irinotecan—Anaphylactic shock—Temozolomide—brain cancer	9.23e-05	0.0013	CcSEcCtD
Irinotecan—Alopecia—Etoposide—brain cancer	9.19e-05	0.0013	CcSEcCtD
Irinotecan—Infection—Temozolomide—brain cancer	9.17e-05	0.00129	CcSEcCtD
Irinotecan—BCHE—central nervous system—brain cancer	9.17e-05	0.0056	CbGeAlD
Irinotecan—CYP3A5—endocrine gland—brain cancer	9.13e-05	0.00557	CbGeAlD
Irinotecan—Anorexia—Carmustine—brain cancer	9.1e-05	0.00128	CcSEcCtD
Irinotecan—CYP2B6—endocrine gland—brain cancer	9.07e-05	0.00554	CbGeAlD
Irinotecan—Nausea—Procarbazine—brain cancer	9.07e-05	0.00128	CcSEcCtD
Irinotecan—Nervous system disorder—Temozolomide—brain cancer	9.05e-05	0.00128	CcSEcCtD
Irinotecan—CES1—Fluoropyrimidine Activity—TP53—brain cancer	9.05e-05	0.00331	CbGpPWpGaD
Irinotecan—Thrombocytopenia—Temozolomide—brain cancer	9.04e-05	0.00127	CcSEcCtD
Irinotecan—BCHE—cerebellum—brain cancer	8.96e-05	0.00547	CbGeAlD
Irinotecan—CYP2B6—head—brain cancer	8.95e-05	0.00547	CbGeAlD
Irinotecan—Hypotension—Carmustine—brain cancer	8.92e-05	0.00126	CcSEcCtD
Irinotecan—Hyperhidrosis—Temozolomide—brain cancer	8.92e-05	0.00126	CcSEcCtD
Irinotecan—Anorexia—Temozolomide—brain cancer	8.8e-05	0.00124	CcSEcCtD
Irinotecan—Back pain—Etoposide—brain cancer	8.75e-05	0.00123	CcSEcCtD
Irinotecan—Hypersensitivity—Hydroxyurea—brain cancer	8.7e-05	0.00123	CcSEcCtD
Irinotecan—Muscle spasms—Etoposide—brain cancer	8.7e-05	0.00123	CcSEcCtD
Irinotecan—ABCG2—cerebellum—brain cancer	8.66e-05	0.00529	CbGeAlD
Irinotecan—Insomnia—Carmustine—brain cancer	8.64e-05	0.00122	CcSEcCtD
Irinotecan—CES1—E2F transcription factor network—CDKN2A—brain cancer	8.61e-05	0.00315	CbGpPWpGaD
Irinotecan—Paraesthesia—Carmustine—brain cancer	8.58e-05	0.00121	CcSEcCtD
Irinotecan—Dyspnoea—Carmustine—brain cancer	8.51e-05	0.0012	CcSEcCtD
Irinotecan—ABCC1—brain—brain cancer	8.5e-05	0.00519	CbGeAlD
Irinotecan—Somnolence—Carmustine—brain cancer	8.49e-05	0.0012	CcSEcCtD
Irinotecan—Asthenia—Hydroxyurea—brain cancer	8.48e-05	0.0012	CcSEcCtD
Irinotecan—Ill-defined disorder—Etoposide—brain cancer	8.4e-05	0.00118	CcSEcCtD
Irinotecan—ABCC1—S1P1 pathway—VEGFA—brain cancer	8.38e-05	0.00306	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—HES1—brain cancer	8.38e-05	0.00306	CbGpPWpGaD
Irinotecan—Anaemia—Etoposide—brain cancer	8.36e-05	0.00118	CcSEcCtD
Irinotecan—Insomnia—Temozolomide—brain cancer	8.35e-05	0.00118	CcSEcCtD
Irinotecan—Decreased appetite—Carmustine—brain cancer	8.3e-05	0.00117	CcSEcCtD
Irinotecan—Paraesthesia—Temozolomide—brain cancer	8.29e-05	0.00117	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Carmustine—brain cancer	8.25e-05	0.00116	CcSEcCtD
Irinotecan—Dyspnoea—Temozolomide—brain cancer	8.23e-05	0.00116	CcSEcCtD
Irinotecan—Somnolence—Temozolomide—brain cancer	8.21e-05	0.00116	CcSEcCtD
Irinotecan—CYP2B6—central nervous system—brain cancer	8.17e-05	0.00499	CbGeAlD
Irinotecan—Constipation—Carmustine—brain cancer	8.17e-05	0.00115	CcSEcCtD
Irinotecan—Pain—Carmustine—brain cancer	8.17e-05	0.00115	CcSEcCtD
Irinotecan—Malaise—Etoposide—brain cancer	8.16e-05	0.00115	CcSEcCtD
Irinotecan—Vertigo—Etoposide—brain cancer	8.13e-05	0.00115	CcSEcCtD
Irinotecan—Dyspepsia—Temozolomide—brain cancer	8.12e-05	0.00115	CcSEcCtD
Irinotecan—Leukopenia—Etoposide—brain cancer	8.1e-05	0.00114	CcSEcCtD
Irinotecan—Diarrhoea—Hydroxyurea—brain cancer	8.08e-05	0.00114	CcSEcCtD
Irinotecan—Decreased appetite—Temozolomide—brain cancer	8.02e-05	0.00113	CcSEcCtD
Irinotecan—ACHE—ATF-2 transcription factor network—PDGFRA—brain cancer	7.98e-05	0.00292	CbGpPWpGaD
Irinotecan—Gastrointestinal disorder—Temozolomide—brain cancer	7.97e-05	0.00112	CcSEcCtD
Irinotecan—Fatigue—Temozolomide—brain cancer	7.96e-05	0.00112	CcSEcCtD
Irinotecan—Loss of consciousness—Etoposide—brain cancer	7.95e-05	0.00112	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.94e-05	0.0029	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—CYP2C9—brain cancer	7.91e-05	0.00289	CbGpPWpGaD
Irinotecan—Cough—Etoposide—brain cancer	7.9e-05	0.00111	CcSEcCtD
Irinotecan—Constipation—Temozolomide—brain cancer	7.89e-05	0.00111	CcSEcCtD
Irinotecan—Pain—Temozolomide—brain cancer	7.89e-05	0.00111	CcSEcCtD
Irinotecan—Feeling abnormal—Carmustine—brain cancer	7.87e-05	0.00111	CcSEcCtD
Irinotecan—Hypertension—Etoposide—brain cancer	7.81e-05	0.0011	CcSEcCtD
Irinotecan—Dizziness—Hydroxyurea—brain cancer	7.81e-05	0.0011	CcSEcCtD
Irinotecan—Gastrointestinal pain—Carmustine—brain cancer	7.81e-05	0.0011	CcSEcCtD
Irinotecan—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	7.8e-05	0.00285	CbGpPWpGaD
Irinotecan—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	7.76e-05	0.00284	CbGpPWpGaD
Irinotecan—ABCB1—telencephalon—brain cancer	7.69e-05	0.00469	CbGeAlD
Irinotecan—Discomfort—Etoposide—brain cancer	7.61e-05	0.00107	CcSEcCtD
Irinotecan—Feeling abnormal—Temozolomide—brain cancer	7.61e-05	0.00107	CcSEcCtD
Irinotecan—Body temperature increased—Carmustine—brain cancer	7.55e-05	0.00106	CcSEcCtD
Irinotecan—Abdominal pain—Carmustine—brain cancer	7.55e-05	0.00106	CcSEcCtD
Irinotecan—Gastrointestinal pain—Temozolomide—brain cancer	7.55e-05	0.00106	CcSEcCtD
Irinotecan—Vomiting—Hydroxyurea—brain cancer	7.51e-05	0.00106	CcSEcCtD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.45e-05	0.00273	CbGpPWpGaD
Irinotecan—Rash—Hydroxyurea—brain cancer	7.45e-05	0.00105	CcSEcCtD
Irinotecan—Confusional state—Etoposide—brain cancer	7.45e-05	0.00105	CcSEcCtD
Irinotecan—Dermatitis—Hydroxyurea—brain cancer	7.44e-05	0.00105	CcSEcCtD
Irinotecan—Headache—Hydroxyurea—brain cancer	7.4e-05	0.00104	CcSEcCtD
Irinotecan—Anaphylactic shock—Etoposide—brain cancer	7.39e-05	0.00104	CcSEcCtD
Irinotecan—Infection—Etoposide—brain cancer	7.34e-05	0.00103	CcSEcCtD
Irinotecan—Body temperature increased—Temozolomide—brain cancer	7.3e-05	0.00103	CcSEcCtD
Irinotecan—Abdominal pain—Temozolomide—brain cancer	7.3e-05	0.00103	CcSEcCtD
Irinotecan—BCHE—brain—brain cancer	7.28e-05	0.00444	CbGeAlD
Irinotecan—Thrombocytopenia—Etoposide—brain cancer	7.23e-05	0.00102	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—brain cancer	7.14e-05	0.00101	CcSEcCtD
Irinotecan—Anorexia—Etoposide—brain cancer	7.04e-05	0.000993	CcSEcCtD
Irinotecan—Hypersensitivity—Carmustine—brain cancer	7.04e-05	0.000992	CcSEcCtD
Irinotecan—ABCG2—brain—brain cancer	7.03e-05	0.0043	CbGeAlD
Irinotecan—Nausea—Hydroxyurea—brain cancer	7.02e-05	0.00099	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.02e-05	0.00257	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.95e-05	0.00254	CbGpPWpGaD
Irinotecan—Hypotension—Etoposide—brain cancer	6.9e-05	0.000973	CcSEcCtD
Irinotecan—Asthenia—Carmustine—brain cancer	6.85e-05	0.000966	CcSEcCtD
Irinotecan—CYP3A4—endocrine gland—brain cancer	6.85e-05	0.00418	CbGeAlD
Irinotecan—Hypersensitivity—Temozolomide—brain cancer	6.8e-05	0.000959	CcSEcCtD
Irinotecan—Paraesthesia—Etoposide—brain cancer	6.63e-05	0.000935	CcSEcCtD
Irinotecan—Asthenia—Temozolomide—brain cancer	6.62e-05	0.000934	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—brain cancer	6.58e-05	0.000929	CcSEcCtD
Irinotecan—ACHE—ATF-2 transcription factor network—CDK4—brain cancer	6.57e-05	0.0024	CbGpPWpGaD
Irinotecan—Somnolence—Etoposide—brain cancer	6.57e-05	0.000926	CcSEcCtD
Irinotecan—Diarrhoea—Carmustine—brain cancer	6.53e-05	0.000922	CcSEcCtD
Irinotecan—CYP2B6—brain—brain cancer	6.49e-05	0.00396	CbGeAlD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	6.46e-05	0.00236	CbGpPWpGaD
Irinotecan—Decreased appetite—Etoposide—brain cancer	6.42e-05	0.000905	CcSEcCtD
Irinotecan—ABCB1—gonad—brain cancer	6.42e-05	0.00392	CbGeAlD
Irinotecan—Gastrointestinal disorder—Etoposide—brain cancer	6.38e-05	0.000899	CcSEcCtD
Irinotecan—Fatigue—Etoposide—brain cancer	6.37e-05	0.000898	CcSEcCtD
Irinotecan—Dizziness—Carmustine—brain cancer	6.32e-05	0.000891	CcSEcCtD
Irinotecan—Constipation—Etoposide—brain cancer	6.32e-05	0.000891	CcSEcCtD
Irinotecan—Pain—Etoposide—brain cancer	6.32e-05	0.000891	CcSEcCtD
Irinotecan—Diarrhoea—Temozolomide—brain cancer	6.31e-05	0.000891	CcSEcCtD
Irinotecan—ABCB1—pituitary gland—brain cancer	6.26e-05	0.00382	CbGeAlD
Irinotecan—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	6.22e-05	0.00228	CbGpPWpGaD
Irinotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.17e-05	0.00226	CbGpPWpGaD
Irinotecan—CYP3A4—central nervous system—brain cancer	6.17e-05	0.00377	CbGeAlD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.12e-05	0.00224	CbGpPWpGaD
Irinotecan—Dizziness—Temozolomide—brain cancer	6.1e-05	0.000861	CcSEcCtD
Irinotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.09e-05	0.00223	CbGpPWpGaD
Irinotecan—Feeling abnormal—Etoposide—brain cancer	6.09e-05	0.000858	CcSEcCtD
Irinotecan—Vomiting—Carmustine—brain cancer	6.07e-05	0.000856	CcSEcCtD
Irinotecan—ABCB1—medulla oblongata—brain cancer	6.04e-05	0.00369	CbGeAlD
Irinotecan—Gastrointestinal pain—Etoposide—brain cancer	6.04e-05	0.000852	CcSEcCtD
Irinotecan—Rash—Carmustine—brain cancer	6.02e-05	0.000849	CcSEcCtD
Irinotecan—Dermatitis—Carmustine—brain cancer	6.02e-05	0.000848	CcSEcCtD
Irinotecan—Headache—Carmustine—brain cancer	5.98e-05	0.000844	CcSEcCtD
Irinotecan—Vomiting—Temozolomide—brain cancer	5.87e-05	0.000828	CcSEcCtD
Irinotecan—CYP2B6—Biological oxidations—CYP2C9—brain cancer	5.85e-05	0.00214	CbGpPWpGaD
Irinotecan—Body temperature increased—Etoposide—brain cancer	5.84e-05	0.000823	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—brain cancer	5.84e-05	0.000823	CcSEcCtD
Irinotecan—CES1—E2F transcription factor network—MYC—brain cancer	5.84e-05	0.00213	CbGpPWpGaD
Irinotecan—Rash—Temozolomide—brain cancer	5.82e-05	0.000821	CcSEcCtD
Irinotecan—Dermatitis—Temozolomide—brain cancer	5.81e-05	0.00082	CcSEcCtD
Irinotecan—Headache—Temozolomide—brain cancer	5.78e-05	0.000815	CcSEcCtD
Irinotecan—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	5.77e-05	0.00211	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	5.75e-05	0.0021	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—CYP2C9—brain cancer	5.72e-05	0.00209	CbGpPWpGaD
Irinotecan—Nausea—Carmustine—brain cancer	5.67e-05	0.0008	CcSEcCtD
Irinotecan—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	5.64e-05	0.00206	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.63e-05	0.00206	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—S100A10—brain cancer	5.55e-05	0.00203	CbGpPWpGaD
Irinotecan—ABCB1—midbrain—brain cancer	5.52e-05	0.00337	CbGeAlD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.51e-05	0.00201	CbGpPWpGaD
Irinotecan—Nausea—Temozolomide—brain cancer	5.48e-05	0.000773	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—brain cancer	5.44e-05	0.000767	CcSEcCtD
Irinotecan—ABCB1—spinal cord—brain cancer	5.39e-05	0.00329	CbGeAlD
Irinotecan—Asthenia—Etoposide—brain cancer	5.3e-05	0.000747	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.27e-05	0.00193	CbGpPWpGaD
Irinotecan—CYP3A4—Irinotecan Pathway—APC—brain cancer	5.24e-05	0.00192	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	5.07e-05	0.00186	CbGpPWpGaD
Irinotecan—Diarrhoea—Etoposide—brain cancer	5.05e-05	0.000713	CcSEcCtD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.04e-05	0.00184	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.04e-05	0.00184	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.01e-05	0.00183	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5e-05	0.00183	CbGpPWpGaD
Irinotecan—Dizziness—Etoposide—brain cancer	4.88e-05	0.000689	CcSEcCtD
Irinotecan—ABCB1—endocrine gland—brain cancer	4.85e-05	0.00296	CbGeAlD
Irinotecan—ABCB1—head—brain cancer	4.79e-05	0.00292	CbGeAlD
Irinotecan—Vomiting—Etoposide—brain cancer	4.7e-05	0.000662	CcSEcCtD
Irinotecan—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	4.67e-05	0.00171	CbGpPWpGaD
Irinotecan—Rash—Etoposide—brain cancer	4.66e-05	0.000657	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—brain cancer	4.65e-05	0.000656	CcSEcCtD
Irinotecan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	4.65e-05	0.0017	CbGpPWpGaD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	4.63e-05	0.00169	CbGpPWpGaD
Irinotecan—Headache—Etoposide—brain cancer	4.63e-05	0.000652	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.62e-05	0.00169	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—TP53—brain cancer	4.44e-05	0.00162	CbGpPWpGaD
Irinotecan—Nausea—Etoposide—brain cancer	4.39e-05	0.000619	CcSEcCtD
Irinotecan—ABCB1—central nervous system—brain cancer	4.37e-05	0.00267	CbGeAlD
Irinotecan—ABCB1—cerebellum—brain cancer	4.27e-05	0.00261	CbGeAlD
Irinotecan—ACHE—ATF-2 transcription factor network—CCND1—brain cancer	4.24e-05	0.00155	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.22e-05	0.00154	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	4.04e-05	0.00148	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	4.03e-05	0.00147	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	4e-05	0.00146	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.86e-05	0.00141	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.86e-05	0.00141	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.81e-05	0.00139	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—SOD2—brain cancer	3.8e-05	0.00139	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	3.8e-05	0.00139	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.61e-05	0.00132	CbGpPWpGaD
Irinotecan—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	3.58e-05	0.00131	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	3.52e-05	0.00129	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.48e-05	0.00127	CbGpPWpGaD
Irinotecan—ABCB1—brain—brain cancer	3.47e-05	0.00212	CbGeAlD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.46e-05	0.00127	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.4e-05	0.00124	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.4e-05	0.00124	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.35e-05	0.00123	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.31e-05	0.00121	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.18e-05	0.00116	CbGpPWpGaD
Irinotecan—ACHE—Peptide hormone metabolism—CTNNB1—brain cancer	3.14e-05	0.00115	CbGpPWpGaD
Irinotecan—ACHE—Phospholipid metabolism—PIK3CG—brain cancer	3.14e-05	0.00115	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.12e-05	0.00114	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—SOD2—brain cancer	3.02e-05	0.0011	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.97e-05	0.00109	CbGpPWpGaD
Irinotecan—BCHE—Peptide hormone metabolism—CTNNB1—brain cancer	2.8e-05	0.00102	CbGpPWpGaD
Irinotecan—BCHE—Phospholipid metabolism—PIK3CG—brain cancer	2.8e-05	0.00102	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.78e-05	0.00102	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—PDGFRA—brain cancer	2.75e-05	0.00101	CbGpPWpGaD
Irinotecan—ABCC1—Disease—DTX2—brain cancer	2.74e-05	0.001	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.72e-05	0.000996	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—RELA—brain cancer	2.7e-05	0.000987	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—CYP2C9—brain cancer	2.66e-05	0.000972	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.64e-05	0.000966	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	2.62e-05	0.000959	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MPL—brain cancer	2.62e-05	0.000956	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.57e-05	0.000939	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.56e-05	0.000937	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.55e-05	0.000931	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—S100A10—brain cancer	2.51e-05	0.000917	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.48e-05	0.000908	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.42e-05	0.000885	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.42e-05	0.000884	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	2.29e-05	0.000839	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	2.25e-05	0.000821	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—RELA—brain cancer	2.2e-05	0.000803	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.17e-05	0.000795	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	2.17e-05	0.000794	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP2C9—brain cancer	2.15e-05	0.000788	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HES5—brain cancer	2.01e-05	0.000736	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL2—brain cancer	1.98e-05	0.000723	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.9e-05	0.000695	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.89e-05	0.000692	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.88e-05	0.000686	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.87e-05	0.000683	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.85e-05	0.000675	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.84e-05	0.000671	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—BSG—brain cancer	1.83e-05	0.00067	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—BSG—brain cancer	1.77e-05	0.000646	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.75e-05	0.000641	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—RELA—brain cancer	1.74e-05	0.000638	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.72e-05	0.000629	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP2C9—brain cancer	1.7e-05	0.00062	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	1.68e-05	0.000615	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.66e-05	0.000606	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.64e-05	0.000601	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.62e-05	0.000594	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP2C9—brain cancer	1.61e-05	0.000588	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP2C9—brain cancer	1.61e-05	0.000588	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—IDH1—brain cancer	1.57e-05	0.000576	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP2C9—brain cancer	1.55e-05	0.000567	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000553	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.51e-05	0.000551	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL2—brain cancer	1.5e-05	0.000549	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.48e-05	0.00054	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000539	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.47e-05	0.000538	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.46e-05	0.000534	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.45e-05	0.000529	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—BSG—brain cancer	1.44e-05	0.000527	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—VEGFA—brain cancer	1.44e-05	0.000527	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.38e-05	0.000506	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	1.37e-05	0.000502	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—BSG—brain cancer	1.37e-05	0.0005	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—BSG—brain cancer	1.37e-05	0.0005	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP2C9—brain cancer	1.37e-05	0.000499	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.36e-05	0.000496	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IDH1—brain cancer	1.35e-05	0.000495	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP2C9—brain cancer	1.35e-05	0.000495	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.33e-05	0.000486	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—BSG—brain cancer	1.32e-05	0.000482	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.3e-05	0.000476	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.29e-05	0.000473	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—BSG—brain cancer	1.29e-05	0.00047	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HEY1—brain cancer	1.28e-05	0.00047	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.28e-05	0.000466	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—brain cancer	1.27e-05	0.000464	CbGpPWpGaD
Irinotecan—ABCC1—Disease—DLL1—brain cancer	1.26e-05	0.00046	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—BSG—brain cancer	1.25e-05	0.000458	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ENO2—brain cancer	1.24e-05	0.000455	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—IDH1—brain cancer	1.24e-05	0.000453	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—IDH1—brain cancer	1.18e-05	0.00043	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—IDH1—brain cancer	1.18e-05	0.00043	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—BSG—brain cancer	1.16e-05	0.000424	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TRPC6—brain cancer	1.16e-05	0.000423	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—BSG—brain cancer	1.15e-05	0.000421	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—IDH1—brain cancer	1.13e-05	0.000415	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.12e-05	0.000409	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—IDH1—brain cancer	1.11e-05	0.000404	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.09e-05	0.000399	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—IDH1—brain cancer	1.08e-05	0.000394	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SHH—brain cancer	1.07e-05	0.000391	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ENO2—brain cancer	1.07e-05	0.000391	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.07e-05	0.000391	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.05e-05	0.000385	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.01e-05	0.000369	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1e-05	0.000367	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP2C9—brain cancer	1e-05	0.000366	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—IDH1—brain cancer	9.98e-06	0.000365	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—IDH1—brain cancer	9.89e-06	0.000362	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ENO2—brain cancer	9.8e-06	0.000358	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP2C9—brain cancer	9.78e-06	0.000358	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.58e-06	0.00035	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ENO2—brain cancer	9.3e-06	0.00034	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ENO2—brain cancer	9.3e-06	0.00034	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.24e-06	0.000338	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.01e-06	0.000329	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ENO2—brain cancer	8.97e-06	0.000328	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.78e-06	0.000321	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.78e-06	0.000321	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ENO2—brain cancer	8.74e-06	0.00032	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VAV1—brain cancer	8.67e-06	0.000317	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ENO2—brain cancer	8.52e-06	0.000312	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BSG—brain cancer	8.51e-06	0.000311	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2C9—brain cancer	8.42e-06	0.000308	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BSG—brain cancer	8.32e-06	0.000304	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.17e-06	0.000299	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ENO2—brain cancer	7.89e-06	0.000289	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ENO2—brain cancer	7.82e-06	0.000286	CbGpPWpGaD
Irinotecan—ABCC1—Disease—VAV1—brain cancer	7.73e-06	0.000283	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	7.52e-06	0.000275	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2C9—brain cancer	7.38e-06	0.00027	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—IDH1—brain cancer	7.32e-06	0.000268	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.22e-06	0.000264	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BSG—brain cancer	7.16e-06	0.000262	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—IDH1—brain cancer	7.15e-06	0.000261	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.15e-06	0.000261	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HES1—brain cancer	6.65e-06	0.000243	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	6.39e-06	0.000234	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PDGFRA—brain cancer	6.33e-06	0.000232	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.29e-06	0.00023	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BSG—brain cancer	6.28e-06	0.000229	CbGpPWpGaD
Irinotecan—ALB—Metabolism—IDH1—brain cancer	6.16e-06	0.000225	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CTNNB1—brain cancer	5.93e-06	0.000217	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.79e-06	0.000212	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ENO2—brain cancer	5.78e-06	0.000211	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CG—brain cancer	5.71e-06	0.000209	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.66e-06	0.000207	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ENO2—brain cancer	5.65e-06	0.000207	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IRS2—brain cancer	5.56e-06	0.000203	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CG—brain cancer	5.51e-06	0.000201	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—IDH1—brain cancer	5.4e-06	0.000197	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CTNNB1—brain cancer	5.29e-06	0.000193	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.01e-06	0.000183	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—brain cancer	4.91e-06	0.00018	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ENO2—brain cancer	4.87e-06	0.000178	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.75e-06	0.000174	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2C9—brain cancer	4.55e-06	0.000166	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CG—brain cancer	4.5e-06	0.000164	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CG—brain cancer	4.27e-06	0.000156	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO2—brain cancer	4.27e-06	0.000156	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CG—brain cancer	4.27e-06	0.000156	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CG—brain cancer	4.11e-06	0.00015	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CG—brain cancer	4.01e-06	0.000147	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—brain cancer	3.91e-06	0.000143	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—brain cancer	3.88e-06	0.000142	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BSG—brain cancer	3.87e-06	0.000141	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—brain cancer	3.81e-06	0.000139	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—brain cancer	3.62e-06	0.000132	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—brain cancer	3.59e-06	0.000131	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—brain cancer	3.34e-06	0.000122	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH1—brain cancer	3.32e-06	0.000122	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—brain cancer	3.29e-06	0.00012	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—brain cancer	2.91e-06	0.000106	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—brain cancer	2.7e-06	9.88e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—brain cancer	2.65e-06	9.7e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—brain cancer	2.64e-06	9.67e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO2—brain cancer	2.63e-06	9.61e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—brain cancer	2.59e-06	9.48e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—brain cancer	2.49e-06	9.1e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—brain cancer	2.23e-06	8.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—brain cancer	1.96e-06	7.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—brain cancer	1.21e-06	4.41e-05	CbGpPWpGaD
